AstraZeneca
inflammatory diseases a a | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
November 2024
Slide
123 of 157
Similar slides by AstraZeneca
See diffirences between slides (animation)
Results
November 2024
factor inhibitor ophthalmology | AstraZeneca
Results
November 2024
factor inhibitor complement mediated disease | AstraZeneca
Results
November 2024
targeting complement nephrology | AstraZeneca
Results
November 2024
kidney targeted factor fusion protein nephrology | AstraZeneca
Related slides by other companies
BioNTech
Results
August 2021
global phase clinical trial in anti melanoma patients | BioNTech
Immix Biopharma
Investor Presentation
August 2023
direct path to line therapy in clinical trial plan cold | Immix Biopharma
Ocuphire Pharma
Results
October 2022
safety summary from phase and phase trials | Ocuphire Pharma
Immix Biopharma
Investor Presentation
January 2024
direct path to line therapy in clinical trial plan nee ara | Immix Biopharma
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Investor Event
September 2024
Results
February 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io